Friday 7/11 Insider Buying Report: CALC, OMCC

CalciMedica (CALC) CBO Eric W. Roberts recently purchased 5,000 shares for $8,024, adding to his four previous buys over the past year, with CALC shares up 17.1% on Friday and his latest purchase already yielding an 18.2% return. Simultaneously, Old Market Capital Corp (OMCC) CFO Charles Krebs made his first insider buy in 12 months, acquiring 1,184 shares for $7,301, as OMCC gained 3.4% on Friday. These recent insider transactions indicate executive confidence, coinciding with positive short-term market performance for both companies.

Analysis

Recent insider buying activity at CalciMedica (CALC) and Old Market Capital Corp (OMCC) provides bullish signals for both firms. At CalciMedica, the Chief Business Officer's purchase of 5,000 shares for $8,024 represents a continued pattern of accumulation, being his fifth such transaction in the past twelve months. This sustained buying, totaling $53,800 at an average price of $2.76, suggests strong executive conviction, especially as the latest purchase was executed at a significantly lower price of $1.60 per share. The market has responded positively, with the stock trading up 17.1% and the CBO's recent position already showing an 18.2% unrealized gain. At Old Market Capital Corp, the Chief Financial Officer's purchase of 1,184 shares for $7,301 is significant as it marks the first insider buy from this executive in the past year, an event that can often signal a positive shift in internal outlook. This transaction coincided with a 3.4% rise in OMCC's stock price.

Key Decisions for Investors

• The pattern of repeated purchases by CalciMedica's CBO, particularly at a price ($1.60) substantially below his one-year average cost ($2.76), suggests a strong belief that the stock is currently undervalued and may warrant further investigation as a potential buying opportunity.
• The Old Market Capital Corp CFO's first insider purchase in over a year is a noteworthy signal that could precede favorable developments; investors should monitor the company for any subsequent positive catalysts or fundamental shifts.
• While insider buying is a positive indicator, the relatively small quantum of these transactions should be considered, and this signal should be used to complement, rather than dictate, a broader investment thesis.